ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
2,537
Screening encounters
2,803
Diagnostic referrals
540
Outstanding pathways
216

Screening pathway

  1. Screening2,803Encounters
  2. Positive finding945Documented findings
  3. Referral540Diagnostic referrals
  4. Follow-up626Diagnostic visits
  5. Outcome324Resolved pathways

Stage totals use different units. Pending pathways: 216. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 4302 · EXP-4302Synthetic · Site D

Full participant history through 2026-03-27, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-01-01
  4. · Diagnostic referral · EXP-4302-T-R
  5. · Barrier documented · Contact difficulty
  6. · Contact attempt · Unsuccessful
  7. · Barrier documented · Appointment coordination
  8. · Diagnostic booking · Initial booking
  9. · Contact attempt · Reached
  10. · Navigation intervention · Coordination support
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-4302-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2026-11-06
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

2537 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-4189 · Expanded synthetic participant 4189Site B — Peri-Urban Access Programme
EXP-4190 · Expanded synthetic participant 4190Site B — Peri-Urban Access Programme
EXP-4194 · Expanded synthetic participant 4194Site C — Rural Outreach Programme
EXP-4195 · Expanded synthetic participant 4195Site C — Rural Outreach Programme
EXP-4196 · Expanded synthetic participant 4196Site E — Resource-Constrained Navigation Programme
EXP-4198 · Expanded synthetic participant 4198Site D — Community Engagement Programme
EXP-4199 · Expanded synthetic participant 4199Site E — Resource-Constrained Navigation Programme
EXP-4202 · Expanded synthetic participant 4202Site E — Resource-Constrained Navigation Programme
EXP-4204 · Expanded synthetic participant 4204Site A — Urban Referral Hub
EXP-4207 · Expanded synthetic participant 4207Site C — Rural Outreach Programme
EXP-4208 · Expanded synthetic participant 4208Site C — Rural Outreach Programme
EXP-4209 · Expanded synthetic participant 4209Site E — Resource-Constrained Navigation Programme
EXP-4210 · Expanded synthetic participant 4210Site A — Urban Referral Hub
EXP-4212 · Expanded synthetic participant 4212Site D — Community Engagement Programme
EXP-4216 · Expanded synthetic participant 4216Site A — Urban Referral Hub
EXP-4217 · Expanded synthetic participant 4217Site B — Peri-Urban Access Programme
EXP-4218 · Expanded synthetic participant 4218Site B — Peri-Urban Access Programme
EXP-4219 · Expanded synthetic participant 4219Site A — Urban Referral Hub
EXP-4222 · Expanded synthetic participant 4222Site A — Urban Referral Hub
EXP-4224 · Expanded synthetic participant 4224Site A — Urban Referral Hub
EXP-4226 · Expanded synthetic participant 4226Site E — Resource-Constrained Navigation Programme
EXP-4227 · Expanded synthetic participant 4227Site A — Urban Referral Hub
EXP-4228 · Expanded synthetic participant 4228Site C — Rural Outreach Programme
EXP-4231 · Expanded synthetic participant 4231Site B — Peri-Urban Access Programme
EXP-4233 · Expanded synthetic participant 4233Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1162
HPV DNA
1223
Cytology
418

Navigation activity

Barrier documented
458
Contact attempt
787
Navigation intervention
193
Diagnostic booking
663
Diagnostic visit
626

Documented barriers

Contact difficulty
146
Transport difficulty
144
Appointment coordination
168

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.